Beginning January 1, 2025, Humira (brand) will be removed from BlueCross BlueShield of South Carolina and BlueChoice HealthPlan’s Lowest Net Cost, Exchange and Premium formularies. Adalimumab biosimilars will instead be the preferred products for each of

From Bluechoice Health Plan of South Carolina: BlueChoice HealthPlan continually evaluates our prescription drug formularies and drug management programs to ensure effective management of quality and costs. We work with a group of independent doctors